Induction of anti-leukemic responses by stimulation of leukemic CD3+ cells with allogeneic stimulator cells

Table 1 Characteristics of newly diagnosed leukemic patients

Pt#	Sex	Age	Diagnosis	WBC	ALC	Peripheral blasts (%)	Cytogenetics molecular markers
1	Female	74	AML	17.1	6.2	6	XX
2	Female	65	AML	7.4	3.6	9	t (4;11), Tetrasomy 8
3	Male	26	CML	336.5	20.2	4	t (9;22)
4	Male	31	AML	9.2	2.7	39	inv (3), Monosomy 7
5	Female	86	AML	54.4	8.2	32	Trisomy 13
6	Male	32	AML	7.1	0.9	12	del (17), t (16;21)
7	Male	84	CMML	39.6	2.4	11	XY
8	Male	62	AML	19.4	2.5	23	inv (16), del (7)
9	Female	29	AML	8.6	4	47	t (11;20), FLT3 ITD+
10	Male	64	AML	138.3	16.6	80	XY, FLT3 ITD+
11	Female	70	AML	12.8	2.4	33	t (11;19)
12	Male	56	CMML	14.4	2.2	14	XY
13	Female	48	CMML	16.3	2.6	19	XX
14	Male	59	ALL	5.1	2.7	45	t (9;22)
15	Female	34	ALL	341.8	23.9	88	XX
16	Male	46	AML	18.5	2.3	73	t (15;17)
17	Male	64	AML	1.2	0.2	3	XY, FLT3 ITD+
18	Female	57	AML	34.5	1.7	9	XX inv (16)
19	Female	32	ALL	58.1	7.3	86	XX Ph+
20	Male	62	AML	28.1	8	9	XY
21	Female	77	AML	84.4	4.2	81	Not sent

ISSN: 2162-3619